JP2022526446A5 - - Google Patents

Info

Publication number
JP2022526446A5
JP2022526446A5 JP2021560596A JP2021560596A JP2022526446A5 JP 2022526446 A5 JP2022526446 A5 JP 2022526446A5 JP 2021560596 A JP2021560596 A JP 2021560596A JP 2021560596 A JP2021560596 A JP 2021560596A JP 2022526446 A5 JP2022526446 A5 JP 2022526446A5
Authority
JP
Japan
Prior art keywords
composition
human
janthinobacterium
seq
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021560596A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526446A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027556 external-priority patent/WO2020210553A1/en
Publication of JP2022526446A publication Critical patent/JP2022526446A/ja
Publication of JP2022526446A5 publication Critical patent/JP2022526446A5/ja
Pending legal-status Critical Current

Links

JP2021560596A 2019-04-09 2020-04-09 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法 Pending JP2022526446A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962920010P 2019-04-09 2019-04-09
US62/920,010 2019-04-09
PCT/US2020/027556 WO2020210553A1 (en) 2019-04-09 2020-04-09 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes

Publications (2)

Publication Number Publication Date
JP2022526446A JP2022526446A (ja) 2022-05-24
JP2022526446A5 true JP2022526446A5 (cg-RX-API-DMAC7.html) 2023-04-18

Family

ID=70476522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560596A Pending JP2022526446A (ja) 2019-04-09 2020-04-09 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法

Country Status (12)

Country Link
US (5) US20220160617A1 (cg-RX-API-DMAC7.html)
EP (1) EP3952848A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022526446A (cg-RX-API-DMAC7.html)
KR (1) KR20220003539A (cg-RX-API-DMAC7.html)
CN (1) CN113853198A (cg-RX-API-DMAC7.html)
AU (1) AU2020271885A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021020247A2 (cg-RX-API-DMAC7.html)
CA (1) CA3132858A1 (cg-RX-API-DMAC7.html)
IL (1) IL287032A (cg-RX-API-DMAC7.html)
MX (1) MX2021012391A (cg-RX-API-DMAC7.html)
SG (1) SG11202111168UA (cg-RX-API-DMAC7.html)
WO (1) WO2020210553A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
SG11202111168UA (en) * 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
US11517597B2 (en) * 2020-09-29 2022-12-06 Chambio Co., Ltd. Method for improving skin condition with postbiotic extract
CN112891343B (zh) * 2021-03-22 2022-04-01 华中农业大学 3-吲哚乙腈在制备抑制新型冠状病毒SARS-CoV-2药物中的应用
TWI890918B (zh) * 2022-01-24 2025-07-21 耀然實業股份有限公司 私密處保養組成物、私密處保養產品及私密處用品
CN114705800A (zh) * 2022-03-25 2022-07-05 重庆市公共卫生医疗救治中心 尿液中生物标志物检测试剂在制备新冠肺炎病毒无症状感染者筛查试剂盒中的用途
AU2023271525A1 (en) * 2022-05-16 2024-12-05 Maruho Co., Ltd. Composition for treating ringworm
US20260021219A1 (en) * 2022-09-30 2026-01-22 Kimberly-Clark Worldwide, Inc. Methods and absorbent articles for inhibiting fecal protease activity
EP4438052A1 (en) * 2023-03-30 2024-10-02 FytagoLife B.V. Plant extract for use in treatment of a fungal infection
KR20260049280A (ko) * 2023-08-07 2026-04-13 로레알 피부 항-노화 치료를 위한 새로운 조성물
KR20250104680A (ko) * 2023-12-29 2025-07-08 한국생명공학연구원 잔티노박테리움 속 균주 또는 비올라세인을 포함하는 발모 촉진 또는 탈모 예방 또는 치료용 조성물
WO2025179157A1 (en) 2024-02-23 2025-08-28 Imvela Corp. Compositions containing indole-derived metabolites and methods of use thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
EP0045718A3 (de) 1980-07-25 1983-01-19 Ciba-Geigy Ag Nasalpräparate und Verfahren zu deren Herstellung
US4900348A (en) 1983-08-02 1990-02-13 The Ohio State University Research Foundation Production of disease suppresive compost and container media, and microorganism culture for use therein
US5081225A (en) 1989-02-09 1992-01-14 E. R. Squibb & Sons, Inc. Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum
JPH05194141A (ja) 1992-01-14 1993-08-03 Mitsubishi Kasei Corp 化粧料
JPH06247964A (ja) 1993-02-22 1994-09-06 Snow Brand Milk Prod Co Ltd 新規生理活性物質ｈｓ−１及びその製造方法
IT1296148B1 (it) 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
US5888396A (en) 1996-12-17 1999-03-30 Perriello; Felix Anthony Bioremediation of pollutants with butane-utilizing bacteria
US6244346B1 (en) 1996-12-17 2001-06-12 Global Biosciences, Inc. Method and apparatus for reducing fouling of injection and recovery wells
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE493139T1 (de) 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US7507402B1 (en) 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US7374753B1 (en) 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US6224863B1 (en) 1998-10-30 2001-05-01 University Of South Carolina Antibiotic composition from alcaligenes species and method for making and using the same
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
EP1212093B1 (en) 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
JP4554745B2 (ja) 1999-11-18 2010-09-29 日本合成化学工業株式会社 乳化重合用分散剤およびその用途
JP2001269699A (ja) 2000-03-24 2001-10-02 Japan Science & Technology Corp 硝酸汚染地下水の直接浄化方法
US20030072829A1 (en) 2001-01-05 2003-04-17 Austin Richard M. Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
AUPS057102A0 (en) 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
WO2003074660A2 (en) 2002-02-28 2003-09-12 New England Biolabs, Inc. Modified chitin binding domain and uses thereof
US20040243076A1 (en) 2003-05-13 2004-12-02 Sca Hygiene Products Ab Hygiene product with a probiotic composition
US7244607B2 (en) 2003-10-01 2007-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Chromobacterium subtsugae sp. nov. for control of insect pests
JP2005126375A (ja) 2003-10-24 2005-05-19 Shimomura Kinue 乳酸飲料水
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
JP2006253864A (ja) 2005-03-09 2006-09-21 Fujitsu Ltd データ蓄積型転送方法及びそのシステム並びに装置
US7385203B2 (en) 2005-06-07 2008-06-10 Hitachi, Ltd. Charged particle beam extraction system and method
KR100802494B1 (ko) 2006-02-24 2008-02-12 (주)한국바이오케미칼 비올라세인을 함유하는 해충 방제제, 항진균제 및 그의제조방법
JP2007227290A (ja) 2006-02-27 2007-09-06 Canon Inc 画像表示装置および映像受信表示装置
CN101659698B (zh) * 2008-08-26 2012-03-28 清华大学 紫色杆菌素合成相关蛋白质系统及其编码基因簇与应用
CN101386834A (zh) * 2008-10-28 2009-03-18 清华大学 生产紫色杆菌素的方法及重组菌
JP2010113169A (ja) 2008-11-07 2010-05-20 Kagawa Univ 凸版印刷用版材及びその製造方法
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
JP2011152687A (ja) 2010-01-27 2011-08-11 Seiko Epson Corp 液体吐出装置の調整方法及び補正値の算出方法
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
KR101982491B1 (ko) 2011-08-30 2019-05-27 아카데미쉬 메디쉬 센트륨 인슐린 저항 예방 및/또는 치료 방법
HUE029357T2 (en) 2012-05-08 2017-02-28 Adaptive Biotechnologies Corp Preparations and devices for measuring and calibrating amplification distortion in multiplex PCR reactions
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
CN105979952B (zh) 2013-11-25 2022-04-08 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
EP4299122A3 (en) 2014-05-07 2024-03-27 The Regents of The University of California Compositions and methods for treating skin and mucous membrane diseases
CN104293703A (zh) * 2014-09-22 2015-01-21 中国农业科学院农产品加工研究所 一种高产紫色杆菌素的兰黑紫色杆菌及其应用
WO2019118984A2 (en) * 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
UA126440C2 (uk) 2018-12-27 2022-10-05 Ігор Семенович Марков Полівалентна комбінована інактивована рідка вакцина проти збудників бактеріальних і грибкових захворювань сечостатевої системи, спосіб її виготовлення і спосіб лікування та профілактики нею
WO2020179999A1 (ko) 2019-03-07 2020-09-10 씨제이제일제당(주) 바실러스 서브틸리스 cjbs303 및 이를 포함하는 조성물
SG11202111168UA (en) * 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes

Similar Documents

Publication Publication Date Title
JP2022526446A5 (cg-RX-API-DMAC7.html)
CA3132858A1 (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
US20210128641A1 (en) Compositions and methods for treating skin and mucous membrane diseases
US8283136B2 (en) Skin treatment compositions
CA3195341A1 (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes
CN113677404B (zh) 聚赖氨酸树枝状聚合物在预防和管理易出现痤疮的皮肤和痤疮皮肤中的应用
EP3849573B1 (en) Bacteriotherapy against proprionibacterium acnes for the treatment of acne
EP3411011B1 (en) Compositions and methods for promoting skin health
US20190249149A1 (en) Compositions and methods for treating acne
CN116761582A (zh) 益生菌皮肤制剂
ES2717119T3 (es) Fracción parietal del Propionibacterium granulosum que tiene acción inmunomoduladora
MX2010010866A (es) Composiciones y metodos para inmunoterapia.
TW202317749A (zh) 用於改善皮膚狀態的組合物以及新型油鞘氨醇單胞菌菌株及其溶解產物、培養液、提取物
WO2024045809A1 (zh) 用于改善哺乳动物毛囊、头皮或毛发健康的方法和组合物
WO2024125471A1 (zh) 用于改善或维持哺乳动物皮肤健康的方法和组合物
RU2021131954A (ru) Композиции и способы улучшения состояния здоровья кожи и лечения, а также предупреждения заболеваний, нарушений и состояний, связанных с патогенными микроорганизмами
JP7240031B2 (ja) ワイセラ属細菌由来のナノ小胞およびその用途
WO2021016347A1 (en) Compositions and methods for treating skin infections and other diseases
EP3015109B1 (en) Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections
CN114375200A (zh) 治疗传染病的药物和方法
US20070184125A1 (en) Use of extracts from gentiana lutea as an antimicrobial agent
HK40066550A (zh) 用於改善皮肤健康和用於治疗和预防与病原微生物相关联的疾病、疾患和病症的组合物和方法
CN110691591A (zh) 用于在治疗寻常痤疮中使用的希波酚
US20210069259A1 (en) Compositions and methods for treating skin infections and other diseases
WO2026010051A1 (ko) 글리세롤 및 이당류를 포함하는 피부 프리바이오틱스 조성물